The gene mutation landscape of acute myeloid leukemia cell lines and its exemplar use to study the BCOR tumor suppressor

Leukemia. 2023 Feb;37(2):473-477. doi: 10.1038/s41375-022-01788-7. Epub 2023 Jan 12.

Affiliations

¹ Institute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy.
² Faculty of Life Sciences, Technical University of Braunschweig, Braunschweig, Germany.
³ Institute of Hematology and Center for Hemato-Oncology Research, Department of Medicine and Surgery, University and Hospital of Perugia, Perugia, Italy. enrico.tiacci@unipg.it.

^# Contributed equally.

PMID: 36635390
DOI: 10.1038/s41375-022-01788-7

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Genes, Tumor Suppressor
Humans
Leukemia, Myeloid, Acute* / genetics
Leukemia, Myeloid, Acute* / pathology
Mutation
Proto-Oncogene Proteins / genetics
Repressor Proteins / genetics
Repressor Proteins / metabolism

Substances

BCOR protein, human
Proto-Oncogene Proteins
Repressor Proteins